Back to Journals » OncoTargets and Therapy » Volume 15

Ovarian Cancer Therapy: Homologous Recombination Deficiency as a Predictive Biomarker of Response to PARP Inhibitors

Total article views   HTML views PDF downloads Totals
8,198 Dovepress* 5,729+ 153 5,882
PubMed Central* 2,469 286 2,755
Totals 8,198 439 8,637
*Since 4 October 2022
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar